What is the realistic management for bladder cancer?

Hello,

Welcome to icliniq.com.

I understand your concern.

First of all, I fully understand and appreciate the fear and anxiety you are experiencing after being diagnosed with metastatic bladder cancer. However, I would like to reassure you that at this stage we now have many treatment modalities available that significantly improve survival, reduce the cancer burden, and enhance quality of life.

At present, since creatinine levels and kidney function are not stable, we would not prefer chemotherapy. Instead, we prefer to proceed with immunotherapy or targeted therapy. Targeted therapy can be associated with side effects such as neuropathy, peripheral numbness, and fatigue, whereas immunotherapy is mainly associated with fatigue, loss of appetite, and mild gastrointestinal upset.

Importantly, immunotherapy does not cause neuropathy or peripheral numbness, which is why we generally prefer it, as its side effect profile is more tolerable. In terms of survival, both immunotherapy and targeted therapy significantly improve survival and quality of life.

However, they can be expensive, so participation in a clinical trial would be ideal, as the treatment would be provided free of charge, along with financial support. Regarding nutrition, we recommend small, frequent meals, focusing on fruits and vegetables, and drinking plenty of fluids.

For bone metastases, we would like to add Denosumab to help increase bone strength and reduce the risk of bone metastases. If there are painful areas, palliative radiotherapy can be given to ease the pain burden. I hope this explanation is clear, and if you need any clarification or have any questions at any time, we are always here to help.

The treatment plan includes immunotherapy, targeted therapy, Denozumab and palliative radiotherapy, and follow-up in seven days.

I hope this helps.

Kindly follow up if you have more concerns.

Thank you.